Darifenacin Tablet, Extended Release
Product Images NDC 72162-2571

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Darifenacin (NDC 72162-2571). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Logo1 (06torrentlogo1)

Logo1 (06torrentlogo1)
FDA Label Image

Logo2 (07torrentlogo2)

Logo2 (07torrentlogo2)
FDA Label Image

Figure1 (Figure 1)

Figure1 (Figure 1)
FDA Label Image

Figure 2a Study 1 (Figure2a Study1)

Figure 2a Study 1 (Figure2a Study1)
FDA Label Image

Figure 2b Study 2 (Figure2b Study2)

Figure 2b Study 2 (Figure2b Study2)
FDA Label Image

Figure 2c Study 3 (Figure2c Study3)

Figure 2c Study 3 (Figure2c Study3)
FDA Label Image

Label (Lbl721622571)

Label (Lbl721622571)
Each film-coated extended-release tablet contains 17.860 mg of Darifenacin Hydrobromide equivalent to 15 mg Darifenacin. It is recommended to store the tablets at 20° to 25°C (68° to 77°F) with excursions permitted between 15° to 30°C (59° to 86°F). Swallow the tablets whole and do not chew, cut, or crush them. Keep the medication out of reach of children and store it in a tight, light-resistant container with a child-resistant closure. This medication is manufactured by Torrent Pharmaceuticals Ltd. and is distributed by Bryant Ranch Prepack, Inc. The package insert contains the usual dosage and prescribing information.*
FDA Label Image

Structure (Structure)

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.